RIVM European Reference Lab for vector-borne infections The European Commission (EC) has designated RIVM as the current European Reference Lab (EURL) for vector-borne viral pathogens.
Number of tuberculosis patients in the Netherlands increased in 2023 compared to 2022 In 2023, 710 people in the Netherlands were diagnosed with tuberculosis (TB). This was 12 per cent more than in 2022, when there were 634. In 2023, 471 patients had pulmonary TB. Of these 417 patients, 213 had open TB – the most contagious type.
More than 3% of adults and 5% of young people have persistent symptoms after COVID-19 More than 3% of adults (aged 26+) reported having persistent long-term symptoms after an infection with the coronavirus SARS-CoV-2, sometimes lasting several years. This is also known as post-COVID or Long COVID. About 5% of young people aged 12–25 years are experiencing these symptoms.
International collaboration essential theme State of Zoonoses 2019 Each year, at the request of the Netherlands Food and Consumer Product Safety Authority, RIVM prepares an overview of the most important zoonoses and indicates their prevalence in the Netherlands.